| Promoting the Quality of Medicines Plus
The role focuses on developing and revising standards, general chapters, and reference materials to support complex drug substances across multiple therapeutic modalities, including peptides, oligonucleotides, carbohydrates, vaccines, therapeutic proteins, and cell and gene therapies. It involves creating guidelines for new analytical technologies and ensuring quality assessment of raw and starting materials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for | Promoting the Quality of Medicines Plus.
| Promoting the Quality of Medicines Plus didn’t post a salary, so this is our estimate from similar listings.
44% below the average for this role
Mass Spectrometry Analyst (Scientist)
Integrated Resources INC
Analytical Scientist
Integrated Resources INC
Analytical Scientist
Integrated Resources INC
Scientist, Bioassay Development
Eli Lilly and Company
CART Scientist
Artech
Associate Director, Quality Control & Analytical Development
Amylyx Pharmaceuticals